Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1468-3083.2008.02666.xDOI Listing

Publication Analysis

Top Keywords

narrow-band ultraviolet
4
ultraviolet phototherapy
4
phototherapy treatment
4
treatment vitiligo
4
vitiligo evidence
4
evidence autoimmune
4
autoimmune pathogenesis
4
narrow-band
1
phototherapy
1
treatment
1

Similar Publications

Psoriasis is a chronic inflammatory skin condition characterized by hyperproliferation of keratinocytes and immune dysregulation. Narrow band ultraviolet B (NB-UVB) phototherapy is a common treatment for psoriasis due to its efficacy and safety profile. NOD2 is an intracellular pattern recognition receptor involved in immune responses and inflammation, and its expression is elevated in psoriatic skin.

View Article and Find Full Text PDF

Vitiligo is a chronic depigmenting condition that causes amelanotic macules and patches on the skin. Despite various treatment options, treating vitiligo is a challenge. This study aimed to evaluate the combination of laser CO fractional and narrow-band ultraviolet B (NB-UVB) versus NB-UVB monotherapy in vitiligo patients.

View Article and Find Full Text PDF

Currently, the development of red Mn-activated fluoride luminescent materials attracts a lot of attention in optical thermometry sensors, solid lighting, display, and plant growth areas. Nevertheless, the thermal stability of Mn-activated fluoride luminescent materials is still a crucial issue. Herein, a new red RbNaVF:Mn luminescent material with outstanding thermal stability was successfully synthesized through the facial coprecipitation method.

View Article and Find Full Text PDF

Exploring new photoexcited phosphors has attracted attention for improving the performance of white LEDs. Here, an NaBaAlBOCl:Eu phosphor with high color purity (94.11%) has been synthesized.

View Article and Find Full Text PDF

Topical Tacrolimus in Vitiligo: Consensus Paper from the Pigmentary Disorders Society.

Clin Cosmet Investig Dermatol

December 2024

Consultant Dermatologist, Indore, Madhya Pradesh, India.

Background: Tacrolimus, a topical calcineurin inhibitor (TCI) with immunomodulatory effects, is considered a viable treatment option for vitiligo. A consensus building exercise was undertaken to determine the role and clinical utility of topical tacrolimus in the management of vitiligo using input from experts in the field of dermatology.

Methods: Seventeen experts collaborated to create consensus statements using a modified Delphi methodology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!